NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
April 16, 2026 — Oncotelic Therapeutics reports $249M net income for FY 2025, driven by GMP Bio JV valuation gain. The biopharma firm is developing OT-101 for cancer & COVID-19, plus 5 nanoparticle compounds.
April 16, 2026 — NextPlat's PharmcoRx subsidiary deploys AI-powered prescription processing technology to automate pharmacy workflows, improve efficiency, and support scalable growth in healthcare management.
April 16, 2026 — Helus Pharma appoints Dr. Ken Kramer as SVP of medical affairs to advance novel mental health treatments. Company developing NSAs for depression and anxiety with FDA breakthrough designation.
April 16, 2026 — Stacey Eisenberg launches Peter's Memory Beads, a tactile brain health tool inspired by a 116-year-old's habit. Proceeds support Alzheimer's Association research.
April 16, 2026 — Catalyst Crew Technologies updates its AI telehealth platform development for Latin America, focusing on remote care and analytics integration to improve healthcare access and efficiency.
April 16, 2026 — Aclarion secures U.S. patent for AI platform analyzing MRI data to identify painful spinal discs, expanding IP portfolio to 64 patents for chronic low back pain diagnosis technology.
April 15, 2026 — GeoVax Labs announces Phase 3 trial plans for GEO-MVA mpox/smallpox vaccine in 2026, addressing global supply constraints with accelerated regulatory pathway and manufacturing readiness.
April 15, 2026 — HeartBeam announces public stock offering to fund commercialization of its FDA-cleared 12-lead ECG system and AI-driven cardiac monitoring tech, enhancing remote heart care.
April 15, 2026 — A Jacksonville family transforms their son's Type 1 diabetes diagnosis into Pablo's Pack T1D, an advocacy initiative providing resources & driving support for the Breakthrough T1D Walk to fund research.
April 15, 2026 — Earth Science Tech (ETST) featured for strategic healthcare acquisitions, including compounding pharmacies and telemedicine platforms. Learn about its value creation approach and subsidiaries like Mister Meds and RxCompoundStore.
April 15, 2026 — Earth Science Tech (ETST) expands its healthcare portfolio with strategic acquisitions in compounding pharmacies and telemedicine, focusing on personalized wellness and shareholder value creation.
April 15, 2026 — Kairos Pharma wins 2026 Pinnacle Award for innovative cancer drug resistance treatments. Learn about ENV-105 clinical trials and their approach to overcoming treatment resistance in oncology.
April 15, 2026 — Polyrizon raises $3.5M for nasal hydrogel technology that creates a biological mask barrier against viruses and allergens. Learn about their innovative Capture and Contain™ platform.
April 15, 2026 — Canadian scientists discover brain cells actively fuel glioblastoma growth, challenging cancer biology. CNS Pharmaceuticals develops new treatments as TinyGems reports on this breakthrough finding.
April 15, 2026 — Tonix Pharmaceuticals publishes study showing TONMYA's faster absorption for fibromyalgia treatment. First new fibromyalgia drug in 15 years with potential for improved sleep and pain management.
April 15, 2026 — Liora Technologies' compact proton therapy system aims to make precision cancer treatment more accessible by reducing size and cost, expanding options for patients.
April 15, 2026 — HeartBeam announces public offering to fund FDA-cleared 3D ECG technology development. Medical tech company aims to revolutionize cardiac care with portable heart monitoring devices.
April 15, 2026 — Zacks analysis validates Soligenix's pipeline progress, highlighting HyBryte™ phase 3 trial for cutaneous T-cell lymphoma and upcoming milestones driving forward outlook for investors.
April 15, 2026 — NeuroOne partners with University of Minnesota to advance sEEG-based drug delivery for epilepsy, aiming to improve precision and reduce side effects in seizure treatment.
April 15, 2026 — New study finds loneliness increases risk of degenerative heart valve disease by 19%, even after accounting for genetics and lifestyle. Research highlights need to address social connection for heart health.